Literature DB >> 20019066

Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.

Sebastiaan J Vastert1, Richard van Wijk, Leila E D'Urbano, Karen M K de Vooght, Wilco de Jager, Angelo Ravelli, Silvia Magni-Manzoni, Antonella Insalaco, Elisabetta Cortis, Wouter W van Solinge, Berent J Prakken, Nico M Wulffraat, Fabrizio de Benedetti, Wietse Kuis.   

Abstract

OBJECTIVE: Macrophage activation syndrome (MAS) in systemic onset juvenile idiopathic arthritis (SoJIA) is considered to be an acquired form of familial haemophagocytic lymphohistiocytosis (fHLH). FHLH is an autosomal recessive disorder, characterized by diminished NK cell function and caused by mutations in the perforin gene (PRF1) in 20-50% of patients. Interestingly, SoJIA patients display decreased levels of perforin in NK cells and diminished NK cell function as well. Here, we analysed PRF1 and its putative promoter in SoJIA patients with or without a history of MAS.
METHODS: DNA of 56 SoJIA patients (41 Italian and 15 Dutch) was isolated. Of these, 15 (27%) had a confirmed history of MAS. We sequenced PRF1 and 1.5 kb of the 5'-upstream region. DNA sequence variations in the promoter region were functionally tested in transfection experiments using a human NK cell line.
RESULTS: We detected a previously undescribed sequence variation (-499 C > T) in the promoter of PRF1 in 18% of the SoJIA patients. However, transfection experiments did not show functional implications of this variation. Secondly, we found that 11 of 56 (20%) SoJIA patients were heterozygous for missense mutations in PRF1. In particular, we found a high prevalence of the Ala91Val mutation, a variant known to result in defective function of perforin. Interestingly, the prevalence of Ala91Val in SoJIA patients with a history of MAS (20%) was increased compared with SoJIA patients without MAS (9.8%). One SoJIA patient, heterozygous for Ala91Val, showed profound decreased perforin levels at the time of MAS.
CONCLUSIONS: These findings suggest that PRF1 mutations play a role in the development of MAS in SoJIA patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019066     DOI: 10.1093/rheumatology/kep418

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  69 in total

1.  Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect.

Authors:  Julien Carvelli; Christelle Piperoglou; Catherine Farnarier; Frédéric Vely; Karin Mazodier; Sandra Audonnet; Patrick Nitschke; Christine Bole-Feysot; Mohamed Boucekine; Audrey Cambon; Mohamed Hamidou; Jean-Robert Harle; Geneviève de Saint Basile; Gilles Kaplanski
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

2.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

3.  Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.

Authors:  Grant S Schulert; Mingce Zhang; Ammar Husami; Ndate Fall; Hermine Brunner; Kejian Zhang; Randy Q Cron; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2018-05-02       Impact factor: 10.995

4.  Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.

Authors:  Kejian Zhang; Michael B Jordan; Rebecca A Marsh; Judith A Johnson; Diane Kissell; Jarek Meller; Joyce Villanueva; Kimberly A Risma; Qian Wei; Peter S Klein; Alexandra H Filipovich
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

5.  Late relapse of primary hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation: a consequence of low-level chimerism from a carrier donor?

Authors:  Amy E Verrinder; Joanna L S Marsden; Mary A Slatter; Leigh McDonald; Chris M Bacon; Joaquim Majo; Andrew R Gennery
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 6.  [Still's disease in children and adults].

Authors:  C M Hedrich; C Günther; M Aringer
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 7.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

8.  Prevalence and disease predisposition of p.A91V perforin in an aged population of European ancestry.

Authors:  Ilia Voskoboinik; Paul Lacaze; Helena Sung-In Jang; Thijs Flinsenberg; Suran L Fernando; Ian Kerridge; Moeen Riaz; Robert Sebra; Kevin Thia; Taherah Noori; Eric E Schadt; John J McNeil; Joseph A Trapani
Journal:  Blood       Date:  2020-02-20       Impact factor: 22.113

9.  Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

Authors:  Grant S Schulert; Mingce Zhang; Ndate Fall; Ammar Husami; Diane Kissell; Andrew Hanosh; Kejian Zhang; Kristina Davis; Jeffrey M Jentzen; Lena Napolitano; Javed Siddiqui; Lauren B Smith; Paul W Harms; Alexei A Grom; Randy Q Cron
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

Review 10.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.